Neonatal drug withdrawal

The Committee on Drugs of the American Academy of Pediatrics recommends that thoughtful consideration be given to the need for administration of pharmacologic agents to newborn infants who have symptoms of drug withdrawal. Supportive care should be the first line of therapy, and objective methods su...

Full description

Saved in:
Bibliographic Details
Published in:Pediatrics (Evanston) 1983-12, Vol.72 (6), p.895-902
Main Authors: PRUITT, A. W, ANYAN, W. R. JR, SMITH, D. L, LICATA, S. A, OAKLEY, G, SAWCHUK, S, FARCHIONE, L, BREWER, E. J, LEER, J. A, HILL, R. M, KAUFFMAN, R. E, MOFENSON, H. C, SINGER, H. S, SPIELBERG, S, BALLIN, J. C, FREEMAN, M. M, NIEBYL, J
Format: Article
Language:English
Subjects:
Antihypertensive Agents - therapeutic use
Antipsychotic Agents - therapeutic use
Biological and medical sciences
Drug addictions
Female
Humans
Hypnotics and Sedatives - therapeutic use
Infant, Newborn
Medical sciences
Narcotics - therapeutic use
Patient Care Team
Pregnancy
Prenatal Exposure Delayed Effects
Substance Withdrawal Syndrome - drug therapy
Substance Withdrawal Syndrome - therapy
Toxicology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Committee on Drugs of the American Academy of Pediatrics recommends that thoughtful consideration be given to the need for administration of pharmacologic agents to newborn infants who have symptoms of drug withdrawal. Supportive care should be the first line of therapy, and objective methods such as an abstinence scoring sheet should be used to determine the need for instituting and then discontinuing pharmacologic treatment. When appropriate, specific drug therapy should be used for treatment of withdrawal symptoms (ie, phenobarbital for phenobarbital withdrawal and opiate for opiate withdrawal). Attention should be given to potential adverse effects in the infant resulting from excipients present in many of the drugs (Table 2). The information provided herein should serve as a guide for the physician in providing supportive care and pharmacologic treatment of the infant suffering from drug withdrawal.
ISSN:0031-4005
1098-4275
DOI:10.1542/peds.72.6.895